Shilpa Medicare gains 4% after Bengaluru unit’s US FDA inspection clearance

The company, in an exchange filing on July 16, said that Unit VI, Dabaspet, Bengaluru, Karnataka, India, has received an EIR with VAI (Voluntary Action Indicated) classification from the US FDA.

Leave a Reply

Your email address will not be published. Required fields are marked *